<DOC>
	<DOCNO>NCT01415830</DOCNO>
	<brief_summary>The morbidity associate scorpion sting intoxication present endemic pattern country , highly venomous specie scorpion scorpion sting intoxication ( IPPA ) consider medical emergency . On hand , scarce scientific literature different control study evaluate anti-scorpion serum , consider clinical severity scale , lab result safety . The aim study compare efficacy safety scorpion sting treatment , use two serum , one produce Birmex versus Alacramyn Â® ( Bioclon ) .</brief_summary>
	<brief_title>Compare Two Anti-Scorpion Venom Serum In Children</brief_title>
	<detailed_description>We consider relevant conduct study poison scorpion bite represent public health problem . This randomized clinical trial , include 120 subject sex age 0 15 year old resident state Guanajuato , divide 2 group : 60 patient receive antiscorpion serum Birmex 60 patient receive commercial serum ( Alacramyn ) .</detailed_description>
	<mesh_term>Scorpion Stings</mesh_term>
	<criteria>1 . Scorpion sting 2 . Either sex 3 . Age 1 15 year 4 . Signing informed consent ( sign parent guardian ) 5 . Being resident state Guanajuato 1 . Previous treatment gamma globulin immunoglobulin 2 . Blood transfusion stage life 3 . Patients treat drug interact antiscorpion serum 4 . History history sensitivity intolerance antiscorpion serum horse product 5 . Pregnancy 6 . Any immunodeficiency 7 . Patients participate research protocol previous month .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>15 Years</maximum_age>
	<verification_date>February 2013</verification_date>
	<keyword>Anti-Scorpion venom serum</keyword>
	<keyword>venom</keyword>
	<keyword>efficacy</keyword>
	<keyword>safety</keyword>
	<keyword>child</keyword>
</DOC>